Drug Type Chemical drugs |
Synonyms HSK 40495, HSK40495 |
Target |
Action inhibitors |
Mechanism PARP1 inhibitors(Poly (ADP-Ribose) polymerase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | China | 09 Apr 2024 | |
HRD positive cancer | Preclinical | China | 09 Apr 2024 | |
HRD positive cancer | Preclinical | China | 09 Apr 2024 |